CVS Health Corporation (NYSE: CVS) is a major player in the healthcare industry, and it’s currently Larry Robbins’ favorite stock, making up 13.76% of his investment portfolio. On February 10, 2026, Reuters reported that CVS posted a decline in fourth-quarter profit but still beat Wall Street expectations. This comes as the company is restructuring after a tough year in 2024.
Despite the dip, CVS shows resilience. Its adjusted earnings per share (EPS) was $1.09, down from $1.19 last year, but better than the expected $0.99. Their revenue went up from $97.70 billion to $105.70 billion, largely due to the boost from assets bought from Rite Aid. Additionally, the number of prescriptions filled rose by 6.3% over the past year.
For 2026, CVS aims for at least $400 billion in revenue, with an adjusted EPS target of $7.00 to $7.20. This indicates they are prioritizing stable management over aggressive growth targets. While the Medicare Advantage costs have put some pressure on their performance, their Aetna unit reported a medical loss ratio of 94.8%, slightly better than expected. However, share prices slipped in premarket trading, reflecting investor caution.
CVS is unique as it combines insurance services, pharmacy management, retail pharmacies, and clinical services under one roof. This integrated approach allows them to offer comprehensive healthcare solutions across the U.S.
It’s worth noting that while CVS has strong potential as an investment, some experts believe certain AI stocks might offer better returns with lower risks. As the tech landscape evolves, many are keeping an eye on shifts in consumer behavior and government policies, especially those that emerged during the Trump administration.
For more insights on investment opportunities, you can check out updated reports and analyses from trusted sources like Yahoo Finance and Reuters.
In summary, CVS Health is navigating challenges well, but the markets remain sensitive to its outlook. As always, staying informed about industry trends and closely monitoring changes can help investors make better decisions.
